Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.72B | 2.82B | 2.97B | 2.78B | 2.12B |
Gross Profit | 1.22B | 1.26B | 1.28B | 1.23B | 787.05M |
EBITDA | 205.54M | 253.94M | 276.31M | 257.08M | -432.19M |
Net Income | 107.25M | 163.87M | 181.74M | 137.02M | -438.99M |
Balance Sheet | |||||
Total Assets | 1.89B | 1.80B | 1.84B | 1.84B | 1.87B |
Cash, Cash Equivalents and Short-Term Investments | 29.64M | 21.36M | 33.70M | 30.11M | 88.30M |
Total Debt | 826.55M | 747.86M | 887.63M | 871.40M | 1.12B |
Total Liabilities | 1.29B | 1.24B | 1.41B | 1.52B | 1.66B |
Stockholders Equity | 599.02M | 560.63M | 420.68M | 318.57M | 200.25M |
Cash Flow | |||||
Free Cash Flow | 55.41M | 150.53M | 61.84M | 144.30M | 104.29M |
Operating Cash Flow | 104.56M | 200.15M | 125.88M | 168.44M | 126.35M |
Investing Cash Flow | -51.69M | -49.62M | -64.04M | -24.14M | -22.06M |
Financing Cash Flow | -44.51M | -162.99M | -58.15M | -202.38M | -61.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $5.90B | 6.45 | 53.70% | ― | 2.09% | 26.18% | |
79 Outperform | $1.92B | 11.41 | 19.51% | 3.17% | 10.17% | -4.71% | |
72 Outperform | $171.31M | 12.50 | 5.97% | 3.38% | -2.01% | 2.08% | |
71 Outperform | $301.54M | 10.37 | 11.76% | 10.51% | -5.46% | -1.09% | |
68 Neutral | $463.69M | 5.73 | 13.67% | 2.04% | -4.84% | -49.08% | |
66 Neutral | $1.65B | 23.03 | 25.29% | 1.96% | -13.05% | ― | |
62 Neutral | C$5.30B | 8.88 | 20.23% | 3.48% | 3.08% | 9.19% |
On June 27, 2025, Caleres, Inc. and its subsidiaries entered into a Seventh Amendment to their Credit Agreement with a group of lenders, extending the maturity date to June 27, 2030, and increasing the credit facility by $200 million to a total of $700 million. This amendment allows for potential further increases and includes changes to permit the acquisition of Stuart Weitzman, while also adjusting covenants and default conditions to ensure financial stability and operational flexibility.
The most recent analyst rating on (CAL) stock is a Hold with a $45.00 price target. To see the full list of analyst forecasts on Caleres stock, see the CAL Stock Forecast page.
On May 22, 2025, Caleres‘ Board of Directors amended the company’s Bylaws to reduce the number of directors from twelve to eleven. During the Annual Meeting of Shareholders on the same day, eleven directors were elected for a one-year term, Ernst & Young LLP was ratified as the independent registered public accountants, and an advisory resolution on executive compensation was approved.
The most recent analyst rating on (CAL) stock is a Hold with a $23.00 price target. To see the full list of analyst forecasts on Caleres stock, see the CAL Stock Forecast page.